Medically reviewed by Amelia MacIntyre, DO The risk of having shingles goes up with age, and people with compromised immune ...
Shingrix grew 19% to £833 million in the quarter, backed up by solid performances for meningitis vaccines Bexsero and Menveo, which rose 34% to £218 million and 40% to £59 million, respectively.
According to recent report from Avalere Health, more than 17 million doses of recommended vaccines, including Shingrix, were missed by adults during the pandemic. Researchers have called for ...